2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

 

ASCO® 2024 Insights: "Atezolizumab & Varlilumab (CDX-1127) +/- Cobimetinib in Previously Treated Unresectable Biliary Tract Cancer"

43 views
June 12, 2024
0 Comments
Login to view comments. Click here to Login